CommunityConnect with experts, uncover more opportunities
1.03K
General
EliteOptionsTrader
·
08-20

TRADE PLAN for Thursday 📈

TRADE PLAN for Thursday 📈 $S&P 500(.SPX)$ another consolidation day today near 7700. SPX needs to get back above 7745 to start looking at calls. if SPX starts to fail, we can see 7620 again. $Invesco QQQ(QQQ)$ is stuck under 722, once it reclaims this level it can pop back up to 726-730. If 712 fails it can drop to 707. $Bitcoin(BTC.USD.CC)$ finally starting to show some signs of life after ten months of consolidation. IF BTC can reclaim 72k it can move to 80k again. $Strategy(MSTR)$ to 115-120 if BTC runs to 72k this month. Chip and memory stocks a
TRADE PLAN for Thursday 📈
Comment
Report
1.30K
General
MMMTWealth
·
08-20

Humanoid Robotics: Public Options Compared – And a Case for Component Suppliers

Humanoids are coming and there are three public options now. We have Unitree (688836) now public at $53B. -> 2025 revenue ~$250M (humanoids were half of that). -> 2025 humanoid shipments ~ 5,500. -> ASPs ~$24k -> Production already demonstrated in the multi-thousand unit annual output range. Nomura has already initiated a 25x (yes...25x) 2027 P/S multiple for Unitree. We have $Churchill Capital Corp XI(CCXI)$ (Agility) expected to go public at $2.5B pre-money. -> Trailing annual revenue ~$37M -> Cash burn ~$100M -> 150 units but 65,000 real world hours -> ~$125k BOM with a path to $30k long0term -> $300M multi-year contracted order. And we have Optimus /
Humanoid Robotics: Public Options Compared – And a Case for Component Suppliers
TOP飘雪111: Yushu is a toy company if it doesn't touch robots
1
Report
588
General
DengDeng
·
08-20
Comment
Report
1.44K
General
Aaronykc
·
08-20
$Tesla Motors(TSLA)$  nice pump yesterday. I'm pretty confident that tsla has bottomed at $298, but $370 will be a real test. It was previous support but was Broken, the 50 simple moving average is at that level as well. There is a high chance that it will drop after filling the gap, which is why I sold a $370 call To collect premium from my 100 shares. Do you think tsla can break the $370 resistance?
$Tesla Motors(TSLA)$ nice pump yesterday. I'm pretty confident that tsla has bottomed at $298, but $370 will be a real test. It was previous suppor...
TOPCyrilDavy: I think it can break 370 if momentum stays clean. That level is crowded for a reason, but a real push through the 50 SMA could squeeze it fast 🚀
1
Report
338
General
Ping23
·
08-20
Comment
Report
1.22K
General
Selling For Premium
·
08-20

Option Strategies: BILL, BABA& DE

Hello everyone! Today i want to share some option strategies with you! 1 Back-to-back meetings from 9am - 12pm are done. Let's do some lunch time #Optionselling trades. Was looking at $Alibaba(BABA)$ $Deere(DE)$ $Wal-Mart(WMT)$ but not liking either the chart set-up or the premium at the strikes we want. Only one that look tempting is $BILL HOLDINGS INC(BILL)$ Sep 18 expiry $32.5 strike puts.
Option Strategies: BILL, BABA& DE
Comment
Report
1.27K
Selection
Buffett followers
·
08-20

Moderna's 177% surge ignites HK biotech rally. Is it still time to buy in?

Today at the opening, Hong Kong-listed innovative drug stocks surged, with $石药集团(01093)$ jumping 14.28%, $药明康德(02359)$ rising 5% to hit a record high, and $百济神州(06160)$ climbing over 3.58%. On the news front, the rally was boosted by a breakthrough in R&D from a U.S. pharmaceutical company. On August 19, $Moderna, Inc.(MRNA)$ and Merck jointly announced the successful Phase III trial of their partnered mRNA vaccine, sending Moderna's stock soaring 176.97% in a single day and adding $40 billion to its market capitalization. This marks the first success
Moderna's 177% surge ignites HK biotech rally. Is it still time to buy in?
TOPcozyzi: I lean no. Moderna's Phase III win is a catalyst, not proof HK biotech rerates can all hold when oncology mRNA conversion has historically been brutal.
2
Report
2.37K
Selection
DipBuyerZ
·
08-20

Moderna Surges 177% and Sparks Biotech Rally — Is It Time to Jump In?

On Wednesday, $Moderna, Inc.(MRNA)$ soared 177%, adding around $44 billion to its market cap, while $默沙东(MRK)$ climbed 12.6%. The ripple effect lifted biotech ETFs across the board. $纳斯达克生物技术指数(NBI)$closed 6.4% higher, notching its biggest single‑day gain in six years.$SPDR S&P Biotech ETF(XBI)$rose 5.9%, $生物科技指数ETF-iShares Nasdaq(IBB)$ gained 6.6%, $iShares Genomics Immunology and Healthcare ETF(IDNA)$ jumped 13.3%, and
Moderna Surges 177% and Sparks Biotech Rally — Is It Time to Jump In?
TOPzippiee: Not yet. MRNA has done this kind of face rip before in 2021 too, then gave back more than 80%
2
Report
599
General
XAUUSD Gold Traders
·
08-20

Gold: Short-Term Top Confirmed, Pullback Accelerates – Medium-Term Bullish Trend Intact

Hello everyone! Today i want to share some macro analysis with you! Currently, after a sharp rally, the market has confirmed short-term top signals and is in a clear phase of accelerating decline ahead of the European market open. $Gold - main 2612(GCmain)$ The bearish “Dark Cloud Cover” pattern indicates that, after reaching an all-time high of 4,527.45, the 4-hour chart has closed with two consecutive bearish candles featuring extremely large real bodies, completely engulfing the real bodies of the previous bullish candles. Technically, this is a classic signal of a top formation and reversal. Currently, there are no signs of a bottoming out indicated by a lower shadow; prices are expected to continue testing the 4,425–4,430
Gold: Short-Term Top Confirmed, Pullback Accelerates – Medium-Term Bullish Trend Intact
Comment
Report
1.05K
General
LanlanCC
·
08-20
CoreWeave, the finance director of cloud provider CoreWeave, downplayed the words during the August performance call: "We recently signed an A100 (Fida chip) contract extending to 2029 at an attractive price. Just a reminder, this model was launched in 2020. 9 years of life!! Actually, is the issue of depreciation actually just that if he does more income, there is no problem. If he can't do it well, it's a big problem. $CoreWeave, Inc.(CRWV)$  
CoreWeave, the finance director of cloud provider CoreWeave, downplayed the words during the August performance call: "We recently signed an A100 (...
TOPPorterLamb: Depreciation is not just an income issue though. Even if revenue lands, accelerated depreciation plus capex can still squeeze cash flow hard
2
Report
512
Selection
Trade_To_Win_Campaign
·
08-20

【08.10-08.16】🏆 Weekly Review | AI Narrative Spills Into Storage! SNDK +35% in a Week — Three Traders, Three Very Different Playbooks

Same storage rally. Three standout traders. Three very different ways to play it. Storage stocks surged last week. SanDisk rallied sharply after its Investor Day on August 13, while other storage names including Micron and Western Digital moved higher as well. All three traders featured this week were bullish on the same theme — but they expressed that view very differently: one rode the move with SNDK shares, one spread exposure across multiple storage names, and another used short-dated options to bet on a breakout. So how did they catch the move? 👀 A quick look at last week's rankings: Prestige Leaderboard TOP 3: 🥇 lkyuptrend · 🥈 David Tan 89 · 🥉 YoMan Elite Leaderboard TOP 3: 🥇 5d0efe97 · 🥈 P.Dwayne · 🥉 Huatge68 Team Leaderboard: 🥇 o.o 🏆 Full rankings at the end of this post. 🧩 Trader
【08.10-08.16】🏆 Weekly Review | AI Narrative Spills Into Storage! SNDK +35% in a Week — Three Traders, Three Very Different Playbooks
Comment
Report
2.28K
Selection
WallStreet_Tiger
·
08-20

🪙 The Great Wall Street Divide: 2 Upgrades, 2 Downgrades — Who's Right About AI's Next Move?

$Alphabet(GOOG)$ and $PayPal(PYPL)$ just got the bull case reloaded. $CrowdStrike Holdings, Inc.(CRWD)$ and $Palantir Technologies Inc.(PLTR)$ just got downgraded. Four calls, two very different views of where money is heading next. On one side: Alphabet, where massive AI spending is finally translating into stronger Cloud growth and a $514B backlog. On the other: CrowdStrike and Palantir, two AI winners still delivering strong growth but trading at valuations that leave much less room for disappointment. PayPal sits somewhere else entirely — its near-term t
🪙 The Great Wall Street Divide: 2 Upgrades, 2 Downgrades — Who's Right About AI's Next Move?
TOP苏36: Alphabet Still Wins Among these four calls, I agree most with the Alphabet upgrade. The key is that Google's AI investment is no longer just a massive spending story. Google Cloud is accelerating, margins are improving, the backlog is huge, and its in-house TPU technology could eventually strengthen both competitiveness and profitability. That gives GOOG a compelling AI re-rating opportunity. I'm more cautious on CRWD and PLTR. Both remain excellent businesses with strong growth, but their valuations already assume years of near-perfect execution. At such multiples, even a small slowdown can trigger a sharp correction. PYPL is the wildcard. The potential M&A deal could create upside, but it is fundamentally an event-driven trade rather than a pure turnaround story. My ranking: GOOG first, PYPL second for aggressive investors, CRWD and PLTR on pullbacks. The lesson is simple: in 2026, AI exposure alone isn't enough — valuation and cash-flow visibility matter. @WallStreet_Tiger [真香]
6
Report
1.55K
Selection
Tiger_Earnings
·
08-20

[Earnings Recap] Estée Lauder Soars 16%, Target Gains 4% — Is the Consumer Rebound?

Consumer earnings were in focus Wednesday, and the market reactions were surprisingly strong. Estée Lauder surged 16% as China and fragrance demand improved, while Target gained 4% after raising its full-year outlook. Lowe’s also moved higher despite softer sales, while TJX fell even after beating expectations. $Estee Lauder(EL)$ +16.3% Estée Lauder is a global beauty company behind brands including Estée Lauder, Clinique, M.A.C, Tom Ford Beauty and Le Labo. Estée Lauder delivered a strong finish to fiscal 2026, with Q4 sales of $3.63 billion, ahead of the $3.54 billion Wall Street expected. Adjusted EPS came in at $0.39, beating the $0.32 consensus. Luxury fragrance remained the standout. Fragrance sales rose 10%, helped by Tom Ford and Le Labo, wh
[Earnings Recap] Estée Lauder Soars 16%, Target Gains 4% — Is the Consumer Rebound?
TOPShyon: If I had to choose between Target and Estée Lauder after earnings, I’d lean toward $Estee Lauder(EL)$ . The 16% jump is significant, but the results suggest its turnaround may finally be gaining traction. Improving China demand and strong fragrance growth from Tom Ford and Le Labo give me more confidence in its recovery. I also like $Target(TGT)$ setup, with stronger traffic, digital sales growth and a raised full-year outlook. However, part of the EPS strength came from tariff refunds, so I’d like to see more evidence that earnings can continue improving without one-off benefits. For me, EL has more upside potential, while TGT is the steadier recovery play. I’d choose EL, but wouldn’t chase the 16% move—I’d rather wait for a pullback and see if the fundamentals continue improving. @TigerStars @TigerClub @Tiger_comments @Tiger_Earnings
2
Report
2.07K
General
闲置多巴胺
·
08-19

NVDA Earnings Review: Fundamental Highlight, But Market Focuses on AI Demand Durability

NVIDIA enters this earnings report with market expectations already set at an unusually high level. Consensus for the current quarter points to revenue of $91.89 billion for the quarter, up 99.50% year over year, EBIT of $60.72 billion, up 110.03% year over year, and EPS of $2.089, up 107.20% year over year. Those forecasts matter not just because they imply another near-doubling in scale, but because they come after a prior quarter in which revenue already reached $81.62 billion, up 85.23% year over year, and profitability stayed exceptionally strong. In practical terms, investors are no longer asking whether NVIDIA is growing fast; the core variable for the stock reaction is whether AI infrastructure demand can keep supporting this pace while preserving margins at levels that remain far
NVDA Earnings Review: Fundamental Highlight, But Market Focuses on AI Demand Durability
TOPfloopi: 71.46% net margin is absurd, but AI demand durability is still the whole debate. If gross margin slips even a bit, this market won't treat a simple beat kindly
1
Report
1.12K
General
zhingle
·
08-19
NVIDIA Drops 2.3% Before Earnings — I’m Still Bullish 🚀 NVIDIA just gave investors a better entry point. Shares fell 2.3% Tuesday, as the entire semiconductor complex sold off, with NVDA now sitting around the $225 area ahead of its Aug. 26 earnings. The market is suddenly questioning whether AI spending has gone too far, whether NVIDIA is financing its own demand, and whether challengers like Cerebras and Groq can finally take share. My take? The market is focusing on the wrong risk. I’m bullish into earnings. 1. The fundamental numbers are still extremely hard to ignore NVIDIA’s last quarter was not a company showing signs of slowing down. Q1 FY27 revenue hit $81.6B, +85% YoY, while Data Center revenue reached $75.2B, +92% YoY. Even more important: NVIDIA guided Q2 revenue to approximate
NVIDIA Drops 2.3% Before Earnings — I’m Still Bullish 🚀 NVIDIA just gave investors a better entry point. Shares fell 2.3% Tuesday, as the entire se...
TOPtwiddly: Capex slowing is the part I can't wave off. If hyperscalers tap the brakes, that bottleneck can turn into inventory pain fast lol
1
Report
789
Selection
Tiger_SG
·
08-20
Markets are being reshaped by oil price swings, inflation, geopolitical tensions and AI-driven earnings. Join us on 21 August for “Q3 Markets Commentary” with Jonathan Lo to unpack the key trends shaping the months ahead.

[Event Registration, For Lv1 - 6 Users] 21st August|Q3 Markets Commentary|Jonathan Lo

@TigerEvents
Oil price volatility continues to shape the interest rate outlook, reinforcing the Fed's higher-for-longer stance amid persistent inflation. Meanwhile, rising geopolitical risks are driving market volatility, even as the expanding AI cycle supports resilient global earnings. Against this backdrop, exposure to different geographical markets may offer varied perspectives on regional economic and market conditions. Join Jonathan Lo, Investment Representative at Tiger Brokers (Singapore), as he explores the macro landscape dominating our mindspace in Q3. 📅 Event Time: 21 August 2026, 7pm - 9pm 📍 Venue: Tiger Brokers Office 🎤 Guest Speaker: Name: Jonathan Lo (RNF: LNH300307561) Title: Investment Representative Company: Tiger Brokers (S
[Event Registration, For Lv1 - 6 Users] 21st August|Q3 Markets Commentary|Jonathan Lo
Markets are being reshaped by oil price swings, inflation, geopolitical tensions and AI-driven earnings. Join us on 21 August for “Q3 Markets Comme...
Comment
Report
750
Selection
Tiger_SG
·
08-20
Looking to invest with greater discipline and conviction? Join us on 27 August for “A Practical Guide to Value Investing in 2026” with Jeremy Tan and explore practical strategies for navigating today’s market.

[Event Registration, For Lv1 - 6 Users] 27th August|A Practical Guide to Value Investing in 2026|Jer

@TigerEvents
Ever wondered how the classic value investing concepts — including margin of safety, Mr. Market and high-ROIC businesses, have evolved through the work of Buffett, Munger, Li Lu and others? Join Jeremy Tan, Investment Representative at Tiger Brokers (Singapore), as he shares how these concepts relate to modern market mechanics, including position sizing, catalysts and options. He will also bring you through the Barbell portfolio approach in global and Singaporean markets, alongside analytical frameworks used to assess global equities and the broader SEA small-cap market. 📅 Event Time: 27 August 2026, 7pm - 9pm 📍 Venue: Tiger Brokers Office 🎤 Guest Speaker: Name: Jeremy Tan (RNF No.: TTJ100095010) Title: Investment Representative Compan
[Event Registration, For Lv1 - 6 Users] 27th August|A Practical Guide to Value Investing in 2026|Jer
Looking to invest with greater discipline and conviction? Join us on 27 August for “A Practical Guide to Value Investing in 2026” with Jeremy Tan a...
Comment
Report
3.22K
General
Hui Fen88
·
08-19

[MINDSET SHIFT] Why You Can Be Wrong 60% of the Time and Still Make Money

Most new traders treat trading like a school exam—they think if they aren't right 80% or 90% of the time, they are failing. This belief causes beginners to hold losing trades forever just to avoid taking a loss and ruining their "win rate." Here is the secret: Win rate doesn't determine profitability—Risk-to-Reward Ratio (R:R) does. What Is Risk-to-Reward Ratio? Your Risk-to-Reward Ratio measures how much money you stand to lose versus how much money you stand to gain on a single trade. 1:1 R:R: You risk $10 to make $10. 1:2 R:R: You risk $10 to make $20. 1:3 R:R: You risk $10 to make $30. The 10-Trade Math Experiment Assume you take 10 trades risking $20 per trade with a 1:3 Risk-to-Reward Ratio. You have a terrible week and lose 6 out of 10 trades (a 40% win rate). Even though you were w
[MINDSET SHIFT] Why You Can Be Wrong 60% of the Time and Still Make Money
TOPMaudNelly: Backtested VOO over the past 5 years, 1:3 with roughly 40% hit rate looked best on paper, but 1:2 was way easier to execute without strategy drift
2
Report
914
General
DengDeng
·
08-20
$Strategy(MSTR)$  still bullish but sold to buy back if I could if there is some retracement, if not move on to other trades
$Strategy(MSTR)$ still bullish but sold to buy back if I could if there is some retracement, if not move on to other trades
Comment
Report
475
General
DengDeng
·
08-20
$IBM(IBM)$  sold another half ibm in this account left with some long call in ibm
$IBM(IBM)$ sold another half ibm in this account left with some long call in ibm
Comment
Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24